fbpx

Resources

Jul 1, 2024

AI model helps predict anti-VEGF response in diabetic macular edema

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema. Luvisi and…

AI model helps predict anti-VEGF response in diabetic macular edema

Jun 25, 2024

Utilizing the immune system to combat dry eye disease

by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED) is a chronic and often progressive condition that can be…

Utilizing the immune system to combat dry eye disease

Jun 25, 2024

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36 months of both continuous monthly and every-other-month treatment. A study…

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

Jun 11, 2024

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The FDA cleared the Abbott Lingo for adults who want to…

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Jun 10, 2024

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint Data presented at the Clinical Trials at the Summit Meeting…

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

Jun 6, 2024

Avirmax Biopharma Inc receives IND approval from FDA

June 6, 2024 by: Martin David Harp The IND approval will allow the company to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular…

Avirmax Biopharma Inc receives IND approval from FDA

Jun 6, 2024

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

A new dry AMD study. The rate of change in the macular area of photoreceptor loss is the primary efficacy endpoint of ReNEW and ReTAIN trials. Stealth BioTherapeutics has enrolled…

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

May 30, 2024

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

      First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients Manassas, VA (May 16, 2024) Digital healthcare provider, Notal Vision,…

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

May 30, 2024

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 28, 2024, by; Lynda Charters Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over 3,000 older adults who satisfied the inclusion criteria in the…

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 22, 2024

Press Release

Discover Hope Macular Degeneration Association Connects Patients with Vital Support Macular Degeneration Association offers free resources and events for all SARASOTA, Fla. (May 14, 2024) – The Macular Degeneration Association…

Press Release

May 12, 2024

Happy Mother’s Day

                                                           …

Happy Mother’s Day

May 3, 2024

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

Low vision can increase your risk of a fall or other mishap. Here’s a room-by-room guide to making your home safer if you have DME. By Maria Masters Medically Reviewed …

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

May 3, 2024

Study finds link between body weight and retinal thickness

There appears to be a significant association between body weight, specifically preobesity and obesity, and changes in retinal thickness, according to a study that suggests individuals who are preobese, even…

Study finds link between body weight and retinal thickness

Apr 16, 2024

Treatment challenges in patients with nAMD

by: Lynda Charters David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab. Reviewed by David Eichenbaum, MD David Eichenbaum, MD, from Retina Vitreous Associates of Florida and the Morsani College…

Treatment challenges in patients with nAMD

Apr 16, 2024

Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

by: Sydney M Crago The Phase 1/2 study includes a dose-escalation phase of the study featuring 3 cohorts each one receiving either a low, medium, or high dose of OCU410.…

Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

Apr 15, 2024

New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain

By Lisa Marie Basile | Fact-checked by Davi Sherman -Published March 29, 2024 Key Takeaways New research has drawn a link between vitamin D deficiency (VDD) and diabetic peripheral neuropathy (DPN) in elderly adults with type…

New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain

Apr 10, 2024

The Complete Eye Health & Nutrition Guide: Eye Foods

New lower price- The Complete Eye Health & Nutrition Guide: Eye Foods New price $15.00 + $9.95 mailing costs- Limited time Please click here to order your today: https://macularhope.org/shop/y7

The Complete Eye Health & Nutrition Guide: Eye Foods

Apr 5, 2024

April is Women’s Eye Health and Safety Mont

Did you know that more women suffer from visual impairments than men, per the National Eye Institute? Two-thirds of blindness occur in women according to the World Health Organization. Fortunately,…

April is Women’s Eye Health and Safety Mont

Apr 4, 2024

SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

by: David Hutton One year after implantation, the enduring IOP reduction remained consistent across all 3 dose strengths.

SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

Apr 3, 2024

ISS National Lab-sponsored study to test a novel gene therapy for AMD

by David Hutton An investigation is set to launch on SpaceX’s 30th Commercial Resupply Services mission to the International Space Station contracted by NASA to test the therapy in space.…

ISS National Lab-sponsored study to test a novel gene therapy for AMD

Apr 2, 2024

Beyond the eclipse: The long-term effects of solar retinopathy

by: David Hutton Patients can experience solar retinopathy after viewing the eclipse without protection, but it also can occur from outdoor activities, including those mentioned. It can lead to symptoms…

Beyond the eclipse: The long-term effects of solar retinopathy

Apr 1, 2024

Eye safety tips you need to know ahead of the solar eclipse

By: Alex Delaney-Gesing Ahead of the much anticipated solar eclipse on April 8, 2024, experts from across the eyecare space are offering their best clinical advice for how to safely…

Eye safety tips you need to know ahead of the solar eclipse

Mar 29, 2024

Happy Easter

The Macular Degeneration Association is wishing you and yours a healthy and happy Easter.

Happy Easter

Mar 28, 2024

Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa

Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa Who Have a Mutation (or Defect) in the RPGR Gene for Their Multi-Center, Phase 2/3 Vista Trial   To be considered for…

Beacon Therapeutics is Seeking Participants with X-linked Retinitis Pigmentosa

Mar 26, 2024

Topical drop treatment for full-thickness macular hole closure

Wang and colleagues conducted a retrospective case series of patients with full-thickness macular holes. A newly reported study, led by first author Jessie Wang, MD, found that topical therapy resulted…

Topical drop treatment for full-thickness macular hole closure

Mar 21, 2024

The Dangers of Rubbing Itchy Eyes

March 18th, 2024 From scratching your cornea and tearing your retina to introducing allergens and causing infections, pawing at your peepers just doesn’t pay off. Rubbing our eyes: It’s something…

The Dangers of Rubbing Itchy Eyes

Mar 19, 2024

The Definitive Guide for Macular Degeneration

Welcome to IrisVision’s live webinar, “The Definitive Guide to Macular Degeneration,” an exclusive session aimed at shedding light on one of the most common causes of vision loss among older…

The Definitive Guide for Macular Degeneration

Mar 8, 2024

Translocated gut bacteria possible cause of some inherited eye diseases

by: Lynda Charters The authors suggested genetic mutation may relax the body’s defenses and allow harmful bacteria to reach the eye. An experimental murine study found that “sight loss in…

Translocated gut bacteria possible cause of some inherited eye diseases

Mar 8, 2024

Brassica Pharma recalls eye ointment products due to lack of sterility assurance

Brassica Pharma has initiated a voluntary recall of its eye ointment products after an FDA inspection of a Brassica facility found a “lack of sterility assurance.” “For those patients who…

Brassica Pharma recalls eye ointment products due to lack of sterility assurance

Feb 20, 2024

February is Low Vision Month

February is Low Vision Month   There are a few ways to define low vision. I think of it as having vision that is not good enough to perform activities…

February is Low Vision Month

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.